Editors’ Section
We would like to welcome Prof Pablo Avanzas as the ISCP President for 2025 and A/Prof Doreen Su-Yin Tan as the President-Elect along with new Board Members Dr Craig Beavers (Governor for USA) and Prof Krzysztof J. Filipiak (Governor for Poland).
Save the Date for the 2025 General Assembly which will be held online, on 7th May at 12:00 GMT. Also Save the Date for the upcoming 30th ISCP Annual Scientific Meeting on the 25th & 26th September, in Oviedo, Spain.
To keep up to date with the ISCP news and invitations on new courses and events, both in-person and online, consider following us on the main social media platforms: LinkTree; X; LinkedIn; Instagram & Facebook.
Please forward any news or information on upcoming conferences or meetings that you would like included in the June 2025 Newsletter to me at lisa.demos@monash.edu by 30 May 2025.
Editors: Lourdes Marenco, John McNeil
& Lisa Demos
President’s Section
Dear colleagues, pharmacists, scientists, educators, healthcare professionals, and all those passionate about advancing the field of cardiovascular pharmacotherapy,
It is with immense pride and a deep sense of responsibility that I welcome you as the new President of the International Society of Cardiovascular Pharmacotherapy (ISCP).
For more than four decades, the ISCP has been at the forefront of promoting scientific innovation, education, and collaboration in cardiovascular pharmacotherapy. During this time, the field has undergone transformative advancements, with novel therapies revolutionizing the management of cardiovascular diseases such as ischemic heart disease, heart failure, atherosclerosis, and cardiometabolic conditions. Yet, our work is far from over. With over 500 new treatments currently in development, we stand on the cusp of an era filled with unprecedented opportunities to improve patient outcomes worldwide.
As a global organization ISCP brings together a diverse and vibrant membership from more than 45 countries. Our mission is clear: to enhance cardiovascular health through education, research, and the promotion of evidence-based pharmacological practices.
ISCP thrives on the contributions of our Chapter Governors, who foster education and collaborative efforts in their respective countries. Through joint sessions with local societies and community-level initiatives, we aim to broaden our reach and impact.
Our official journal, the European Cardiovascular Reviews (ECR), serves as a platform for disseminating high-quality scientific knowledge and fostering dialogue among researchers and clinicians worldwide.
Diversity, equity, and inclusion are core principles of ISCP. We are committed to providing equitable opportunities for individuals of all backgrounds, regardless of race, gender, religion, ethnicity, or orientation. This commitment strengthens our mission and enriches our collective contributions to the global community.
I invite you to join us in this journey—whether through participating in our educational programs, contributing to our scientific discourse, or engaging in collaborative research. Together, we can drive forward the understanding and application of cardiovascular pharmacotherapy to improve lives across the globe.
Thank you for your dedication to this vital cause. I look forward to working with you and witnessing the strides we will make together in advancing cardiovascular health.
Sincerely,
Prof Pablo Avanzas
ISCP President 2025
ISCP News
2025 GENERAL ASSEMBLY
It is with great pleasure that we invite you to the ISCP General Assembly 2025, which will take place online on Wednesday, May 7, 2025, at 12:00 BST. This annual gathering is a key moment for our society, providing an opportunity to review the past year, discuss future plans, and make important decisions together.
We strongly encourage all paying members to attend, as your participation is vital to the continued success of our society. Should you have any questions or topics you wish to raise during the Assembly, please feel free to reach out in advance. We look forward to your presence and valuable contributions.
30TH ANNUAL SCIENTIFIC MEETING ISCP 2025
The ISCP 30th Annual Scientific Meeting is set to take place on September 25 & 26, 2025, at the Oviedo Congress and Exhibitions Centre. This milestone event will bring together world-renowned experts to discuss the latest advancements in cardiovascular pharmacotherapy, covering topics such as coronary disease, heart failure, arrhythmias, dyslipidaemia, hypertension, diabetes, cardio-oncology, and AI-driven therapy innovations.
Don’t miss this unique opportunity to engage with global leaders, exchange insights with peers, and enhance your clinical practice. Stay tuned for updates and the preliminary program on our website and the official meeting site: https://iscp2025oviedo.com/. We look forward to welcoming you to ISCP 2025 in Oviedo!
ACC Asia 2025 Together with SCS 36th Annual Scientific Meeting
The programme includes a joint session with ISCP featuring many ISCP Board Members and Governors on the 10th May 2025. For more information on the meeting and the full programme visit their official website.
ISCP EDUCATIONAL PROGRAMMES & EVENTS
Pharmacy Meets Cardiovascular Medicine – Diabetes, Adiposity, and Associated Diseases / 4th & 5th April 2025 / PMU Salzburg, Austria
This exciting two-day event will take place on April 4–5, 2025, in Salzburg, Austria, bringing together experts and professionals from the fields of pharmacy and cardiovascular medicine for an engaging and insightful exchange of knowledge. The congress is jointly organized by VIVIT (Vorarlberg Institute for Vascular Investigation and Treatment) and PMU Salzburg University, with the endorsement of ISCP. It will feature a comprehensive programme, offering a mix of lectures and presentations in both English and German. Discussions will focus on highly relevant topics, including diabetes, adiposity, and associated diseases, among others. More info here.
UPCOMING WEBINARS
A to Z of CV Pharmacotherapy Webinars: The next webinar “Mineralocorticoid Receptor Antagonist in the Art of Managing HFpEF” is going live on 14th May and will feature Dr Vebiona Kartini Prima Putri (Governor for Indonesia) as moderator, Dr Craig J. Beavers (USA) as the speaker, and panelists PharmDs Bassam Atallah and Lorenz Van der Linden. Keep visiting our website for information on sessions and new resources.
WATCH ON-DEMAND NOW
Managing Iron Deficiency in Heart Failure: Practical Considerations was held on March 19 @ 12:00pm GMT. The expert panel included Ms Wong Yii Ching (Malaysia) as the Moderator, Dr Robert John Mentz (USA) – Speaker; and Panelists: Dr Craig Beavers (USA) and Mr Paul Wright (UK).
Anticoagulation Stewardship – Let’s Start a Global Revolution. This FREE live webinar which was hosted in collaboration with AC Forum was held on Wednesday, 22 January 2025. The moderator was Craig Beavers (USA), speaker Allison E. Burnett (USA) and panellists Gheorghe Andrei Dan (Romania) and Hadley Bortz (Australia).
Clinical Application of Real-World Evidence for Atrial Fibrillation (AF) & Venous Thromboembolism (VTE) International Learning Series (CARE-AF/VTE): This ISCP Endorsed and ACForum hosted, free and comprehensive 2-part, 8-week accredited learning series ran from January 13 – March 3, 2025. The individual AF and VTE units were accredited for up to 2.5 hours of continuing education credits for physicians, nurses, and pharmacists. The full 8-week program was eligible for up to 5.0 hours.
INTERESTED IN TAKING PART IN ISCP EDUCATIONAL PROGRAMMES?
One of the many benefits of being an ISCP Member is to be considered as a keynote speaker for our live webinars, to be part of the panel as an Expert, or to publish articles such as Expert Opinions on novel information that is relevant to the cardiovascular pharmacotherapy community. If you wish to take active part in our educational activities, please send an email to lourdesmarenco@iscpcardio.org with your areas of interests to discuss your involvement further.
OTHER INITIATIVES WE SUPPORT
Practice-Based Research Study Related to Potassium and Barriers to GDMT in Heart Failure
Through our Board Member & ISCP Governor in the USA, Dr Craig Beavers, researchers at the University of Kentucky are inviting you to take part in an IRB approved research survey assessing the cardiovascular clinician’s opinion regarding potassium monitoring and use of guideline directed medical therapy in heart failure. If you are a cardiovascular clinician, you are in a position to provide much valuable information concerning this topic. As a member of the cardiovascular community, you are being invited to participate in this study and so we ask your help in completing the survey: Take the survey here
News from World Heart Federation (WHF)
Emerging Leaders Programme in 2025 will be held in Houston, Texas, USA, from 20 to 24 October 2025, on the topic of leveraging Artificial Intelligence (AI) in the field of cardiovascular disease.
Strengthening Global Partnerships to Combat Cardiovascular Disease: ACC President Cathie Biga and WHF President Jagat Narula in a new JACC Leadership Page.
The World Heart Federation (WHF) announced the appointment of its new CEO, Mr Finn-Jarle Rode. He will take up his position 1 May 2025, with Borjana Pervan serving as the Chief Operating Officer. Their Science Advisor Pablo Perel will remain as the interim CEO until Mr Rode joins WHF.
European Cardiology Review (ECR) – Official ISCP Journal
As a PubMed-indexed, peer-reviewed, gold open access journal, ECR delivers expertly curated content, including balanced review articles, systematic reviews, expert opinions, and editorials. Under the leadership of Editor-in-Chief Juan Carlos Kaski and Associate Editor Pablo Avanzas, alongside an esteemed editorial board of globally recognized physicians, the journal provides valuable insights into key developments in cardiology.
Beyond its articles, the ECR website offers a wealth of resources, including special focus collections, webinars, on-demand videos, and podcasts, ensuring readers stay informed on the latest advancements.
ECR Volume 20 is now available, with all articles free to access and download via the journal’s website. A reminder that ISCP Full Members have access to a 50% discount in publication fees. For those interested in contributing, please reach out to Ola Wisniewska at ola.wisniewska@radcliffe-group.com
ISCP Book Series: Current Cardiovascular Therapy
The Current Cardiovascular Therapy Series provides both an in-depth view of the science and pharmacology behind these drugs and a practical guide to their usage. Each volume contains practical illustrations and is designed to improve understanding and practical usage of cardiovascular drugs in specific clinical areas.
The Springer series includes 9 books available as e-books or in softcover at a discounted rate for ISCP members. These include: Antiplatelet and Anticoagulation Therapy; Pharmacological Treatment of Acute Coronary Syndromes; Atrial Fibrillation Therapy; Cardiac Drugs in Pregnancy; Pharmacotherapy in Aortic Disease; Pharmacologic Trends of Heart Failure; Pharmacological Treatment of Chronic Stable Angina Pectoris; ACEi and ARBS in Hypertension and Heart Failure; Treatment of Pulmonary Hypertension
Upcoming Meetings, Courses and Workshops
Pharmacy Meets Cardiometabolic Medicine
4-5 April 2025
PMU Salzburg University, Austria
ESC Preventive Cardiology 2025
3-5 April 2025
Milan, Italy
APSC 2025
17-19 April 2025
Busan, South Korea
ACC Asia 2025
9-11 May 2025
Singapore
Heart Failure 2025
17 – 20 May 2025
Belgrade, Serbia
10th Edition World Heart Summit
17-18 May 2025
Geneva, Switzerland
ESC and WHF Congress Cardiology 2025
29 August -1 September 2025
Madrid, Spain
ISCP 2025 SPAIN
25-26 September 2025
Oviedo, Spain
Social Media
We are actively using the platforms below and all-important updates on new courses and events are announced through those channels so to keep up to date please give us a follow & share our news with your colleagues and peers. FOLLOW US!
- LinkTree https://linktr.ee/iscpcardio
- X https://x.com/ISCPcardio
- LinkedIn https://www.linkedin.com/company/international-society-of-cardiovascular-pharmacotherapy/
- YouTube https://www.youtube.com/@iscpcardio
To unsubscribe to the Newsletters please notify: Lisa Demos at lisa.demos@monash.edu or Lourdes Marenco at lourdesmarenco@iscpcardio.org
